Mobile version of Hanspub

文章引用说明 更多>> (返回到该文章)

S. Morita, I. Okamoto, K. Kobayashi, et al. Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations. Clinical Cancer Research, 2009, 15(13): 4493-4498.

被以下文章引用: